Real-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With HIV Starting Therapy With AIDS-Defining Conditions: Results From the CoRIS Cohort—The ACTUAS II Study
In light of our results, BIC/FTC/TAF is an effective and well-tolerated option for starting ART in people with AIDS.
Authors
- Chiara Fanciulli (ORCID: https://orcid.org/0000-0003-2175-9027)
- Antonio Rivero (ORCID: https://orcid.org/0000-0002-8643-4250)
- Víctor Asensi (ORCID: https://orcid.org/0000-0003-4211-456X)
- Marina Gallo
- Ignacio Valero (ORCID: https://orcid.org/0000-0002-3488-7135)
- Luz Martı́n-Carbonero (ORCID: https://orcid.org/0000-0001-8102-4079)
- Sonia Calzado Isbert
- Ángela Camacho Espejo
- Diana Corona‐Mata (ORCID: https://orcid.org/0000-0002-8059-7171)
- Alejandro García García (ORCID: https://orcid.org/0000-0003-4896-6528)
- Cristina Hernández Gutiérrez
- Antonio Rivero Juárez
Institutions
- Universitat Autònoma de Barcelona (ES)
- Universidad de Alcalá (ES)
- Hospital Universitario La Paz (ES)
- Instituto de Salud Carlos III (ES)
- Hospital General Universitario Gregorio Marañón (ES)
- University of Córdoba (CO)
- Instituto Maimónides de Investigación Biomédica de Córdoba (ES)
- Hospital La Paz Institute for Health Research (ES)
- Hospital Universitario Príncipe de Asturias (ES)
- Centro de Investigación Biomédica en Red (ES)
- Corporació Sanitària Parc Taulí (ES)
- Hospital Universitario Reina Sofía (ES)
- Hospital Universitario Central de Asturias (ES)
- Institute of Research and Innovation Parc Tauli (ES)
- Hospital Universitario Ramón y Cajal (ES)
- University of Córdoba (ES)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1093/cid/ciaf162
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00